CAD1.41
6.00% today
Toronto, Apr 03, 06:44 pm CET
ISIN
CA42249X1006
Symbol
AIDX

Healwell AI Target price 2025 - Analyst rating & recommendation

Healwell AI Classifications & Recommendation:

Buy
100%

Healwell AI Price Target

Target Price CAD3.81
Price CAD1.50
Potential
Number of Estimates 8
8 Analysts have issued a price target Healwell AI 2026 . The average Healwell AI target price is CAD3.81. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 8 Analysts recommend Healwell AI to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Healwell AI stock has an average upside potential 2026 of . Most analysts recommend the Healwell AI stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million CAD 38.97 136.48
432.38% 250.22%
EBITDA Margin -60.48% 0.84%
60.51% 101.39%
Net Margin -82.31% 2.47%
93.51% 103.00%

8 Analysts have issued a sales forecast Healwell AI 2025 . The average Healwell AI sales estimate is

CAD136m
Unlock
. This is
250.22% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CAD139m 255.40%
Unlock
, the lowest is
CAD135m 245.65%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 CAD39.0m 432.38%
2025
CAD136m 250.22%
Unlock
2026
CAD191m 39.68%
Unlock
2027
CAD222m 16.29%
Unlock
2028
CAD252m 13.48%
Unlock

8 Analysts have issued an Healwell AI EBITDA forecast 2025. The average Healwell AI EBITDA estimate is

CAD1.1m
Unlock
. This is
104.91% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CAD6.2m 126.46%
Unlock
, the lowest is
CAD-5.0m 78.30%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 CAD-23.6m 110.26%
2025
CAD1.1m 104.85%
Unlock
2026
CAD16.9m 1,374.84%
Unlock
2027
CAD27.0m 59.97%
Unlock
2028
CAD33.8m 25.22%
Unlock

EBITDA Margin

2024 -60.48% 60.51%
2025
0.84% 101.39%
Unlock
2026
8.84% 952.38%
Unlock
2027
12.16% 37.56%
Unlock
2028
13.42% 10.36%
Unlock

1 Analyst has issued a net profit forecast Healwell AI 2025 . The average Healwell AI net profit estimate is

CAD3.4m
Unlock
. This is
110.54% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CAD3.4m 110.54%
Unlock
, the lowest is
CAD3.4m 110.54%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 CAD-32.1m 65.45%
2025
CAD3.4m 110.54%
Unlock
2026
CAD11.8m 249.70%
Unlock

Net Margin

2024 -82.31% 93.51%
2025
2.47% 103.00%
Unlock
2026
6.20% 151.01%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share CAD -0.19 0.02
65.45% 110.53%
P/E 75.00
EV/Sales 2.03

1 Analysts have issued a Healwell AI forecast for earnings per share. The average Healwell AI EPS is

CAD0.02
Unlock
. This is
110.53% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
CAD0.02 110.53%
Unlock
, the lowest is
CAD0.02 110.53%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 CAD-0.19 65.45%
2025
CAD0.02 110.53%
Unlock
2026
CAD0.07 250.00%
Unlock

P/E ratio

Current -7.76 351.16%
2025
75.00 1,066.49%
Unlock
2026
21.43 71.43%
Unlock

Based on analysts' sales estimates for 2025, the Healwell AI stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.12 122.50%
2025
2.03 71.45%
Unlock
2026
1.46 28.41%
Unlock
2027
1.25 14.00%
Unlock
2028
1.10 11.87%
Unlock

P/S ratio

Current 6.54 153.08%
2025
1.87 71.45%
Unlock
2026
1.34 28.40%
Unlock
2027
1.15 14.01%
Unlock
2028
1.01 11.87%
Unlock

Current Healwell AI Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
ALLIANCE GLOBAL PARTNERS
Locked
Locked
Locked Dec 19 2024
CLARUS SECURITIES
Locked
Locked
Locked Dec 03 2024
VENTUM FINANCIAL CORP.
Locked
Locked
Locked Dec 03 2024
EIGHT CAPITAL
Locked
Locked
Locked Dec 02 2024
STIFEL CANADA
Locked
Locked
Locked Dec 02 2024
BEACON SECURITIES
Locked
Locked
Locked Nov 12 2024
HAYWOOD SECURITIES INC.
Locked
Locked
Locked Nov 12 2024
Analyst Rating Date
Locked
ALLIANCE GLOBAL PARTNERS:
Locked
Locked
Dec 19 2024
Locked
CLARUS SECURITIES:
Locked
Locked
Dec 03 2024
Locked
VENTUM FINANCIAL CORP.:
Locked
Locked
Dec 03 2024
Locked
EIGHT CAPITAL:
Locked
Locked
Dec 02 2024
Locked
STIFEL CANADA:
Locked
Locked
Dec 02 2024
Locked
BEACON SECURITIES:
Locked
Locked
Nov 12 2024
Locked
HAYWOOD SECURITIES INC.:
Locked
Locked
Nov 12 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today